WebNov 29, 2024 · COTEMPLA XR-ODT is an extended-release orally disintegrating tablet intended for once daily administration. COTEMPLA XR-ODT contains approximately 25% immediate-release and 75% extended-release methylphenidate. Methylphenidate is ionically-bound to the sulfonate of polystyrene sulfonate particles. WebMETHYLPHENIDATE / DEXMETHYLPHENIDATE Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT*, Daytrana, Jornay PM, Metadate CD, Metadate ER, Relexxii*, …
Cotempla XR-ODT: Package Insert - Drugs.com
WebJul 16, 2024 · INDICATIONS. COTEMPLA XR-ODT is indicated for the treatment of Attention Deficit Hyperactivity Disorder in pediatric patients 6 to 17 years of age [see Clinical Studies].. DOSAGE AND … WebFeb 14, 2024 · Brand names of methylphenidate include Ritalin, Ritalin LA, Concerta, Metadate CD, Methylin, Methylin ER, Daytrana, Quillivant XR, Quillichew ER, Aptensio XR, Cotempla XR-ODT, Jornay PM, and Adhansia XR. Methylphenidate is a central nervous system stimulant used for the treatment of attention-deficit hyperactivity disorder (ADHD). suitability checklist
Cotempla XR-ODT: Uses, Dosage, Side Effects, Warnings - Drugs.com
WebJul 1, 2024 · Advise patients and their caregivers that COTEMPLA XR-ODT is a federally controlled substance, and it can be abused or lead to dependence [see Drug Abuse and Dependence (9.1, 9.2, and 9.3)] . Instruct patients that they should not give COTEMPLA XR-ODT to anyone else. Advise patients to store COTEMPLA XR-ODT in a safe place, … WebNov 29, 2024 · The efficacy of COTEMPLA XR-ODT was evaluated in a laboratory classroom study conducted in 87 pediatric patients (Aged 6 to 12 years) with ADHD. Following washout of previous methylphenidate medication, there was an open-label dose-optimization period (4 weeks) with an initial dose of 17.3 mg of COTEMPLA XR-ODT … WebJul 16, 2024 · Cotempla XR ODT is a prescription medicine used to treat the symptoms of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy. Cotempla XR ODT may be used alone or with other … suitability chart